Muscle Activation in Knee Osteoarthritis

November 30, 2023 updated by: University of Pecs

Gender Difference of Muscle Activation Amongst Patients With Knee Osteoarthritis

Muscle activity, as a possible fundamental cause of functional limitation, has been extensively investigated in knee osteoarthritis (KOA). Many trials investigated muscle activity during dynamic movements and functional tasks in KOA. In addition, gender-related differences has been also investigated during functional movements in KOA. However, no trial investigated gender-related differences in muscle activation during static movement in KOA.

Study Overview

Status

Completed

Conditions

Detailed Description

Muscle activity, as a possible fundamental cause of functional limitation, has been extensively investigated in knee osteoarthritis (KOA). Interestingly, studies concentrated mainly on investigation of muscle activity during dynamic movements and different functional tests. Moznuzzaman et al displayed greater muscle activation during sitting to standing test (STS) and standing to sitting test in KOA patients compared to healthy participants. Interestingly, some studies investigated muscle activation standing up from a knee-height seat during STS and illustrated a greater muscle activation amongst KOA patients compared to healthy controls. Moreover, Amer et al found greater muscle activation while performing STS from a lower height seat compared to a knee-height seat amongst women and men patients with uni/bilateral KOA. These findings might be of interest due to compensatory mechanisms observed by female patients during STS transition increases loading on the joint surfaces and consequently leading to progression of KOA. Furthermore, different studies also presented gender-differences of muscle activation during different weight-bearing tasks (gait, STS, stair ascend/descend, and squat) amongst patients with KOA and healthy control. Interestingly, both studies showed women with KOA representing higher muscle activation compared to men. Therefore, an analytical comparative study might be useful for identification of gender-differences in muscle activation amongst patients with KOA.

Investigation of static muscle activity during functional movements is very rare in KOA. Zhang et al investigated muscle activation after single whole body vibration trial in standing position at 0°, 30° and 60° static knee flexion angles amongst women with KOA. Authors found that muscle activation in 60° was greater compared to 30°, and it was also greater in 30° compared to 0°. Based on our literature search, no further study examined muscle activity in static knee flexion in KOA. However, investigating static knee flexion might be useful as it could be related to different knee moments in KOA.

Study Type

Observational

Enrollment (Actual)

70

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Baranya
      • Pécs, Baranya, Hungary, 7621
        • University of Pecs

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients with radiologically diagnosed KOA

Description

Inclusion Criteria:

  • radiologically diagnosed KOA based on the Kellgren-Lawrence grading system 1-3,
  • age above 60 years
  • at least 60° active knee flexion
  • sufficient mental status

Exclusion Criteria:

  • acute inflammation of the knee
  • intraarticular injections within the last 3 months
  • total knee replacement in the opposite side
  • class II obesity (body mass index, BMI>35kg/m2)
  • severe degenerative lumbar spine disease (e.g., spondylolisthesis)
  • systemic inflammatory arthritic or neurological condition
  • conservative intervention attendance within 6 months
  • contraindication to conservative therapy and manual therapy
  • unstable heart condition
  • complex regional pain syndrome

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Men group
Muscle activity amongst men with KOA
Electromyography (EMG) measurement of m. quadriceps femoris and semitendinosus muscle during static functional tasks
Women group
Muscle activity amongst women with KOA
Electromyography (EMG) measurement of m. quadriceps femoris and semitendinosus muscle during static functional tasks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patients' baseline state
Time Frame: within 1 day
Measurement of patients' pain, stiffness and functional state based on WOMAC
within 1 day
Patients' baseline pain
Time Frame: within 1 day
Measurement of patients' pain based on Numeric Pain Rating Scale
within 1 day
Patients' baseline knee flexion
Time Frame: within 1 day
Measurement of patients' active knee flexion in supine
within 1 day
Patients' baseline knee flexion in standing position
Time Frame: within 1 day
Measurement of patients' active knee flexion during weight-bearing
within 1 day
Muscle strength of m. quadriceps femoris
Time Frame: within 1 day
Measurement of muscle strength of m. quadriceps femoris in 0, 35 and 60 degree
within 1 day
Muscle strength of hamstring muscles
Time Frame: within 1 day
Measurement of muscle strength of m. semitendinosus, semimembranosus and biceps femoris in 0, 35 and 60 degree
within 1 day
Muscle activation in 30 degree static knee flexion
Time Frame: within 1 day
EMG measurement of muscle activation during 2-leg 30 degree static knee flexion
within 1 day
Muscle activation in 60 degree static knee flexion
Time Frame: within 1 day
EMG measurement of muscle activation during 2-leg 60 degree static knee flexion
within 1 day
Muscle activation during stepping up a stair
Time Frame: within 1 day
EMG measurement of muscle activation during stepping up on a stair
within 1 day
Muscle activation during stepping down a stair
Time Frame: within 1 day
EMG measurement of muscle activation during stepping down from a stair
within 1 day
Muscle activation during stepping down side-ways a stair with affected leg
Time Frame: within 1 day
EMG measurement of muscle activation during stepping down side-ways a stair with affected leg
within 1 day
Muscle activation during stepping down side-ways a stair with opposite leg
Time Frame: within 1 day
EMG measurement of muscle activation during stepping down side-ways a stair with opposite leg
within 1 day
Muscle activation in one-leg standing position
Time Frame: within 1 day
EMG measurement of muscle activation in one-leg standing position
within 1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Csaba Melczer, Physiother., University of Pecs

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 30, 2023

Primary Completion (Actual)

November 1, 2023

Study Completion (Actual)

November 30, 2023

Study Registration Dates

First Submitted

May 2, 2023

First Submitted That Met QC Criteria

May 19, 2023

First Posted (Actual)

May 23, 2023

Study Record Updates

Last Update Posted (Estimated)

December 1, 2023

Last Update Submitted That Met QC Criteria

November 30, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • Muscle Activation

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Osteoarthritis

Clinical Trials on Electromyography (EMG) measurement

Subscribe